1. Home
  2. AXTI vs ABOS Comparison

AXTI vs ABOS Comparison

Compare AXTI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • ABOS
  • Stock Information
  • Founded
  • AXTI 1986
  • ABOS 1996
  • Country
  • AXTI United States
  • ABOS United States
  • Employees
  • AXTI N/A
  • ABOS N/A
  • Industry
  • AXTI Semiconductors
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • ABOS Health Care
  • Exchange
  • AXTI Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • AXTI 84.8M
  • ABOS 72.7M
  • IPO Year
  • AXTI 1998
  • ABOS 2021
  • Fundamental
  • Price
  • AXTI $2.36
  • ABOS $1.31
  • Analyst Decision
  • AXTI Strong Buy
  • ABOS Strong Buy
  • Analyst Count
  • AXTI 4
  • ABOS 4
  • Target Price
  • AXTI $4.64
  • ABOS $6.50
  • AVG Volume (30 Days)
  • AXTI 455.8K
  • ABOS 797.6K
  • Earning Date
  • AXTI 07-31-2025
  • ABOS 08-12-2025
  • Dividend Yield
  • AXTI N/A
  • ABOS N/A
  • EPS Growth
  • AXTI N/A
  • ABOS N/A
  • EPS
  • AXTI N/A
  • ABOS N/A
  • Revenue
  • AXTI $96,029,000.00
  • ABOS N/A
  • Revenue This Year
  • AXTI N/A
  • ABOS N/A
  • Revenue Next Year
  • AXTI $28.89
  • ABOS N/A
  • P/E Ratio
  • AXTI N/A
  • ABOS N/A
  • Revenue Growth
  • AXTI 21.44
  • ABOS N/A
  • 52 Week Low
  • AXTI $1.13
  • ABOS $0.86
  • 52 Week High
  • AXTI $4.03
  • ABOS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 60.82
  • ABOS 56.77
  • Support Level
  • AXTI $2.10
  • ABOS $1.21
  • Resistance Level
  • AXTI $2.62
  • ABOS $1.50
  • Average True Range (ATR)
  • AXTI 0.17
  • ABOS 0.08
  • MACD
  • AXTI 0.00
  • ABOS 0.02
  • Stochastic Oscillator
  • AXTI 60.61
  • ABOS 52.50

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: